Trial Profile
Efficacy of Empagliflozin on Acute Coronary Syndrome with Type 2 Diabetes: Open-label Randomized Controlled Trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 May 2016
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary)
- Indications Coronary disorders
- Focus Therapeutic Use
- 27 May 2016 New trial record